110 related articles for article (PubMed ID: 9051042)
1. Breast MR imaging: interpretation model.
Nunes LW; Schnall MD; Orel SG; Hochman MG; Langlotz CP; Reynolds CA; Torosian MH
Radiology; 1997 Mar; 202(3):833-41. PubMed ID: 9051042
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.
Nunes LW; Schnall MD; Siegelman ES; Langlotz CP; Orel SG; Sullivan D; Muenz LA; Reynolds CA; Torosian MH
AJR Am J Roentgenol; 1997 Aug; 169(2):409-15. PubMed ID: 9242744
[TBL] [Abstract][Full Text] [Related]
3. Update of breast MR imaging architectural interpretation model.
Nunes LW; Schnall MD; Orel SG
Radiology; 2001 May; 219(2):484-94. PubMed ID: 11323476
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
[TBL] [Abstract][Full Text] [Related]
5. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation model.
Nunes LW; Schnall MD; Orel SG; Hochman MG; Langlotz CP; Reynolds CA; Torosian MH
Radiographics; 1999; 19(1):79-92. PubMed ID: 9925393
[TBL] [Abstract][Full Text] [Related]
6. High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters.
Tozaki M; Igarashi T; Matsushima S; Fukuda K
Radiat Med; 2005 Feb; 23(1):43-50. PubMed ID: 15786751
[TBL] [Abstract][Full Text] [Related]
7. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.
Orel SG; Schnall MD; LiVolsi VA; Troupin RH
Radiology; 1994 Feb; 190(2):485-93. PubMed ID: 8284404
[TBL] [Abstract][Full Text] [Related]
8. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
9. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
10. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy.
Orel SG; Schnall MD; Powell CM; Hochman MG; Solin LJ; Fowble BL; Torosian MH; Rosato EF
Radiology; 1995 Jul; 196(1):115-22. PubMed ID: 7784554
[TBL] [Abstract][Full Text] [Related]
11. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
12. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
13. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence.
Fütterer JJ; Yakar D; Strijk SP; Barentsz JO
Eur J Radiol; 2008 Jan; 65(1):66-71. PubMed ID: 18164156
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of a dedicated 1.5-T breast MR imaging system.
Hillman BJ; Harms SE; Stevens G; Stough RG; Hollingsworth AB; Kozlowski KF; Moss LJ
Radiology; 2012 Oct; 265(1):51-8. PubMed ID: 22923716
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.
Frei KA; Kinkel K; Bonel HM; Lu Y; Esserman LJ; Hylton NM
AJR Am J Roentgenol; 2000 Dec; 175(6):1577-84. PubMed ID: 11090379
[TBL] [Abstract][Full Text] [Related]
17. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
18. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Kubo M; Tokunaga E; Yamamoto H; Honda H
Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900
[TBL] [Abstract][Full Text] [Related]
19. Detection of breast malignancy: diagnostic MR protocol for improved specificity.
Huang W; Fisher PR; Dulaimy K; Tudorica LA; O'Hea B; Button TM
Radiology; 2004 Aug; 232(2):585-91. PubMed ID: 15205478
[TBL] [Abstract][Full Text] [Related]
20. Optimal post-contrast timing of breast MR image acquisition for architectural feature analysis.
Nunes LW; Englander SA; Charafeddine R; Schnall MD
J Magn Reson Imaging; 2002 Jul; 16(1):42-50. PubMed ID: 12112502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
